The latest news from academia, regulators
research labs and other things of interest
Posted: Jun 30, 2017
Mussel-inspired property of dopamin introduced to nanoparticles for tumor targetting
(Nanowerk News) A group of researchers in Korea have synthesized an amphiphilic hyaluronic acid-ceramide-dopamine (HACE-d) conjugate and introduced the mussel-inspired properties of dopamine into the nanoparticles for tumor-specific delivery of phloretin and in vivo visualization of cancer.
Various tumor targeting strategies to deliver anticancer agents selectively to tumor region use an enhanced permeability and retention (EPR) effect to avoid rapid clearance of the nanocarriers from the bloodstream.
Previously, researchers already have reported the mussel-inspired property of dopamine included in marine mussel adhesive proteins, and dopamine with catecholamine groups had been used for enhancing
In this present work, the scientists fabricated HACE-d/phloretin nanoparticles with 279 nm mean diameter, 0.2 polydispersity index, and -18 mV zeta potential. Along with the HA-CD44 receptor binding-intermediated endocytosis of HACE-d nanoparticles, dopamine group exposed in the outer layer of nanocarriers seems to improve cellular accumulation efficiency and subsequent in vitro antitumor efficacy in MDA-MB-231 cells (a line of human breast cancer cells).
Using a MDAMB-231 spheroid model, the researchers observed enhanced infiltration and superior spheroid growth inhibitory effect of HACE-d nanoparticles, in comparison with HACE nanoparticles.
This means that, according to the results of real-time optical imaging studies in a tumor bearing mouse, improved tumor targeting and penetration can be achieved with HACE-d nanoparticles rather than HACE nanoparticles.
The team points out that the HACE-d/phloretin nanoparticles group also exhibited improved anticancer activities, compared with their other experimental groups, in the tumor bearing mouse.
"The combination of passive targeting (an enhanced permeability and retention effect), active targeting (HA-CD44 receptor interaction), improved cellular adhesion and tumor penetration of dopamine residue, and glycolysis inhibition of phloretin may be an unprecedented tumor targeting and penetration approach, and it can be successfully applied for the therapy and imaging of CD44 receptor and GLUT1-expressed cancers," the authors conclude.